← Back to companies
✚ Biotech
Eli Lilly LLY
Pharma company leading the obesity and diabetes drug revolution.
Live chart · TradingView
What it does
Makes tirzepatide (Mounjaro and Zepbound), insulins, cancer and immunology drugs, and Kisunla for Alzheimer’s.
- Ticker
- NYSE:LLY
- Headquarters
- Indianápolis, EUA
- Founded
- 1876
Evidence Radar
✓ Evidence
- Mounjaro and Zepbound among the world’s best-selling drugs.
- Kisunla approved in the US in 2024.
◷ Promises
- An oral obesity pill (orforglipron).
- Expand manufacturing to meet demand.
⚠ What could go wrong
- Political pressure on drug prices.
- Competition from Novo Nordisk and new entrants.
- Revenue concentrated in a few products.
Educational content. Not a recommendation to buy or sell any asset.